Yes, methotrexate is a DMARD, and it’s considered the first-line DMARD for rheumatoid arthritis by every major rheumatology organization in the world. It belongs specifically to the category of conventional synthetic DMARDs, a group that also includes sulfasalazine, leflunomide, and hydroxychloroquine. Understanding what that classification means in practice helps explain why methotrexate is prescribed the way it is and what to expect if you’re taking it.
What “DMARD” Actually Means
DMARD stands for disease-modifying antirheumatic drug. The key word is “disease-modifying.” Unlike painkillers or anti-inflammatory drugs that only mask symptoms, DMARDs work by slowing or stopping the underlying disease process that causes joint damage. Without a DMARD, conditions like rheumatoid arthritis progressively destroy cartilage and bone. DMARDs change that trajectory.
There are several categories of DMARDs. Methotrexate falls into the conventional synthetic group, meaning it’s a chemically manufactured small molecule rather than a protein derived from living cells. The other major category is biologic DMARDs, which are engineered proteins that target specific parts of the immune system. Biologics are newer, more expensive, and typically reserved for people who don’t respond adequately to conventional options like methotrexate.
Why Methotrexate Is the Preferred First Choice
Both the American College of Rheumatology and the European Alliance of Associations for Rheumatology recommend methotrexate as the starting point for treating rheumatoid arthritis with moderate to high disease activity. The 2022 European guidelines state that methotrexate should be part of the first treatment strategy in virtually all cases, unless a patient can’t tolerate it or has a specific contraindication like significant kidney problems. When methotrexate isn’t an option, leflunomide or sulfasalazine are the usual alternatives.
This first-line status comes from decades of clinical data showing that methotrexate is effective, relatively affordable, and well understood. It also plays a unique supporting role: when patients do need to step up to a biologic DMARD, methotrexate is often continued alongside it. Combining methotrexate with a biologic improves disease control, remission rates, and physical function compared to using either drug alone. A systematic review found that combination therapy produced 20% to 57% higher response rates than methotrexate by itself, without increasing the rate of serious side effects.
How It Works Against Inflammation
Methotrexate was originally developed as a cancer drug at much higher doses. At the lower doses used for autoimmune conditions, it works through different pathways. Two main mechanisms drive its anti-inflammatory effects: it promotes the release of adenosine, a natural molecule your body uses to dial down inflammation, and it interferes with certain chemical reactions that immune cells need to sustain an inflammatory response. The net result is a broad dampening of the overactive immune activity that drives joint destruction in rheumatoid arthritis.
Dosing Is Weekly, Not Daily
One of the most important things to know about methotrexate is that it’s taken once a week. For rheumatoid arthritis, the typical starting dose is 7.5 mg per week, which can be gradually increased up to 20 to 25 mg per week depending on the form (tablets or injection). For psoriasis, starting doses range from 2.5 to 10 mg weekly, with a maximum of 30 mg per week.
Taking methotrexate daily instead of weekly is a serious and potentially fatal error. If you ever accidentally take your dose on the wrong schedule, contact a healthcare provider or poison control immediately. Many pharmacies and prescribers now build in extra safeguards, like labeling the specific day of the week you should take it, to prevent this mistake.
How Long It Takes to Work
Methotrexate is not a fast-acting drug. You won’t feel a difference in the first few days or even the first few weeks. Most treatment guidelines recommend continuing methotrexate for at least six months before making a final judgment about whether it’s working for you. If you see no improvement at all within the first three months, your doctor may reassess sooner. This slow timeline can feel frustrating, but it reflects how the drug works: it’s gradually recalibrating your immune system rather than simply blocking pain signals.
Folic Acid and Side Effects
Most people on methotrexate are also prescribed folic acid, typically taken on a different day of the week. This isn’t optional or cosmetic. Methotrexate lowers folate levels in your liver, red blood cells, and immune cells. Restoring those levels with a folic acid supplement reduces side effects like nausea, mouth sores, and liver enzyme elevations. Multiple controlled trials and meta-analyses have confirmed that folic acid supplementation also reduces the number of people who have to stop methotrexate because of intolerance. Common recommended doses fall between 5 and 10 mg per week, though the exact amount varies by prescriber.
Regular Blood Tests Are Required
Because methotrexate affects the liver and blood cell counts, you’ll need regular blood monitoring while taking it. The standard recommendation is monthly blood tests for at least the first six months, then every three months after that. These tests check liver enzymes and blood cell levels. If your liver enzymes rise above three times the normal upper limit and stay there, your doctor will likely pause or stop the medication. This monitoring catches problems early, long before they cause symptoms you’d notice on your own.
Who Should Not Take Methotrexate
Methotrexate is classified as a Category X drug in pregnancy, meaning it can cause fetal death and birth defects. It’s strictly contraindicated during pregnancy and breastfeeding. Both women and men planning to conceive need to stop methotrexate well in advance, as the drug can affect sperm and egg quality.
People with chronic liver disease, cirrhosis, or active alcohol use disorder should not take methotrexate for rheumatoid arthritis or psoriasis. The drug is processed through the liver, and adding it to an already compromised liver significantly raises the risk of serious damage. Significant kidney impairment is another contraindication, since the kidneys are responsible for clearing methotrexate from the body. If clearance is impaired, the drug accumulates to toxic levels.
Methotrexate Beyond Rheumatoid Arthritis
While rheumatoid arthritis is the condition most closely associated with methotrexate, it’s also FDA-approved for psoriasis and used off-label for other autoimmune conditions like lupus, inflammatory bowel disease, and certain types of vasculitis. In all of these contexts, it functions as a DMARD: suppressing the misdirected immune activity that drives the disease rather than just treating symptoms. The dosing, monitoring, and folic acid supplementation protocols are similar across these conditions, though the specific targets may vary.